503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.86%
Negative net income growth while BB stands at 151.39%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.92%
Some D&A expansion while BB is negative at -6.25%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-208.20%
Negative yoy deferred tax while BB stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.47%
SBC growth while BB is negative at -20.00%. John Neff would see competitor possibly controlling share issuance more tightly.
132.15%
Slight usage while BB is negative at -123.68%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
115.46%
AR growth while BB is negative at -153.13%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-170.81%
Negative yoy inventory while BB is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
121.28%
Lower AP growth vs. BB's 106275.68%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
142.54%
Some yoy usage while BB is negative at -250.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
134.20%
Some yoy increase while BB is negative at -282.54%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
75.32%
Some CFO growth while BB is negative at -226.67%. John Neff would note a short-term liquidity lead over the competitor.
8.95%
CapEx growth of 8.95% while BB is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
-2102.24%
Both yoy lines negative, with BB at -200.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-248.22%
Both yoy lines negative, with BB at -20.36%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
118.36%
Proceeds from sales/maturities above 1.5x BB's 42.26%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-1226.97%
We reduce yoy other investing while BB is 637.50%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1292.85%
We reduce yoy invests while BB stands at 96.83%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
63.92%
Lower share issuance yoy vs. BB's 300.00%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-18.69%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.